Doug's Daily Diary
Options Profits/AAO
More Trading Strategies
This Could be the Next Biogen
Ginko Bioworks has great potential for science and investors.
A Market Stirred, Not Shaken
The mixed action on Monday is not a negative -- and here's why SPACs are getting interesting again.
Jim Cramer: The Best of Breed Always Get It Right, But Can Facebook?
Companies don't become best of breed unless they are the best in everything they do. Facebook hangs in the balance.
Secondary Names Get a Look as Rotation Takes Place
Traders continue to hunt for good action as the gap narrows between extended big-cap stocks and beat-down smaller names.
Let's Dissect Lockheed Martin's F-35 Production News
The announcement is welcome because it ensures production predictability, though deliveries scheduled for next year have come down a bit.
Index Trends Remain Split
Forward earnings estimates dip as the 10-Year Treasury yield rises.
Tutor Perini Sees Its Valuation Go Old School as It Slides Into 'Net/Net' Land
The construction company's shares are trading below net current asset value, which is a rarity among value stocks in the current market.
HNA Group's Restructuring Suggests Evergrande's Future Path
The parent of Hainan Airlines looks set to emerge from bankruptcy after its top executives were arrested and the Chinese state stepped in.
A Peculiar Week, Political Maelstrom, Q3 Earnings Season, Time to Sell Nvidia?
The real crisis is not that the Evergrande story will be back, but that China isn't able and politically willing to be the global driver of economic growth it has been.
As the Third Quarter Comes to an End, Bulls Will Keep Pushing
When the market fails to embrace the negative thesis, folks with idle cash slower put it to work.